Chandra Preeti, Dahiya Saurabh, Sanchez-Petitto Gabriela, Malik Jawad, Bolanos Jonathan, Haririan Abdolreza, Weir Matthew, Drachenberg Cinthia, Rapoport Aaron
Division of Nephrology.
Division of Hematology Oncology, and.
Clin Nephrol Case Stud. 2021 Jul 1;9:81-86. doi: 10.5414/CNCS110538. eCollection 2021.
Use of granulocyte colony-stimulating factor (G-CSF) has been associated with side effects including reports of acute glomerulonephritis (GN), almost all of which have been immune complex associated. There is one prior report of pauci-immune GN in a child, but was negative for ANCA (anti-neutrophilic cytoplasmic antibodies). We describe the first case of ANCA-positive pauci-immune GN exacerbated by the use of G-CSF for peripheral blood stem cell (PBSC) donation in a patient with no prior history of vasculitis. Given the use of G-CSF in PBSC donation and neutropenias associated with various conditions, it is important that both the nephrologist and the hematologist are aware of the renal risks associated with its use.
使用粒细胞集落刺激因子(G-CSF)已被发现与副作用有关,包括急性肾小球肾炎(GN)的报告,几乎所有这些都与免疫复合物有关。之前有一份关于儿童寡免疫性GN的报告,但抗中性粒细胞胞浆抗体(ANCA)检测为阴性。我们描述了首例在无血管炎病史的患者中,因使用G-CSF进行外周血干细胞(PBSC)捐献而加重的ANCA阳性寡免疫性GN病例。鉴于G-CSF在PBSC捐献中的使用以及与各种情况相关的中性粒细胞减少症,肾病学家和血液学家都了解其使用相关的肾脏风险非常重要。